News about Global Pharma

Sandoz enters commercialization pact with Bio-Thera Solutions for biosimilar bevacizumab

Sandoz enters commercialization pact with Bio-Thera Solutions for biosimilar bevacizumab

Sandoz, a Novartis division, announced that it has entered into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT1706)

Global Pharma | 09/09/2021 | By Darshana

US FDA approves Pfizer-BioNTech vaccine, Comirnaty for prevention of Covid-19 disease in individuals 16 years of age and older

US FDA approves Pfizer-BioNTech vaccine, Comirnaty for prevention of Covid-19 disease in individuals 16 years of age and older

The US Food and Drug Administration (FDA) approved the first covid-19 vaccine. The vaccine has been known as the Pfizer-BioNTech Covid-19 vaccine, and will now be marketed as Comirnaty (koe-mir?-na-tee), for the prevention of Covid-19 disease in individuals 16 years of age and older

Global Pharma | 24/08/2021 | By Darshana

Daewoong Pharma, Hanall Biopharma expand global collaboration initiative by investing in Boston-based Alloplex Biotherapeutics

Daewoong Pharma, Hanall Biopharma expand global collaboration initiative by investing in Boston-based Alloplex Biotherapeutics

Daewoong Pharmaceutical and Hanall Biopharma of South Korea are expanding their global open collaboration initiative by investing in Alloplex Biotherapeutics, an emerging biotechnology company based in Boston

Global Pharma | 21/08/2021 | By Darshana

US FDA approves Roche?s companion diagnostic test, Ventana MMR RxDx Panel to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy

US FDA approves Roche?s companion diagnostic test, Ventana MMR RxDx Panel to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy

Roche announced US Food and Drug Administration (FDA) approval of the Ventana MMR RxDx Panel, advancing the company's commitment to personalised healthcare through tests that determine which patients are most likely to benefit from specific and targeted therapies

Global Pharma | 20/08/2021 | By Darshana

Pfizer and BioNTech submit phase I data to US FDA to support booster dose of Covid-19 vaccine

Pfizer and BioNTech submit phase I data to US FDA to support booster dose of Covid-19 vaccine

Pfizer and BioNTech announced that they have submitted phase 1 data to the US Food and Drug Administration (FDA) to support the evaluation of a third, or booster, dose of the companies? Covid-19 vaccine (BNT162b2) for future licensure

Global Pharma | 18/08/2021 | By Darshana

BioReference Labs buys US Ariosa centralized laboratory prenatal testing business from Roche

BioReference Labs buys US Ariosa centralized laboratory prenatal testing business from Roche

BioReference Laboratories, Inc., an OPKO Health company announced the acquisition of the US Ariosa centralized laboratory prenatal testing business from Roche.<br />

Global Pharma | 18/08/2021 | By Darshana

Health Gorilla, Ambra Health ink partnership for seamless digital medical imaging

Health Gorilla, Ambra Health ink partnership for seamless digital medical imaging

Ambra Health, maker of the leading cloud-based, medical image management suite, and Health Gorilla, the leading provider of healthcare APIs, announced a partnership to enable medical image viewing directly within Health Gorilla?s platform

Global Pharma | 09/08/2021 | By Darshana

Ispen, Exicure ink collaboration to research, develop and commercialize spherical nucleic acids for Huntington?s disease & Angelman syndrome

Ispen, Exicure ink collaboration to research, develop and commercialize spherical nucleic acids for Huntington?s disease & Angelman syndrome

Ipsen and Exicure have signed an exclusive collaboration agreement to research, develop, and commercialize novel spherical nucleic acids (SNAs) as potential investigational treatments for Huntington?s disease and Angelman syndrome

Global Pharma | 03/08/2021 | By Darshana

AbbVie, Calico Life extend partnership to discover & develop new therapies

AbbVie, Calico Life extend partnership to discover & develop new therapies

AbbVie and Calico Life Sciences announced an extension of their leading-edge collaboration to discover, develop and bring to market new therapies for patients with age-related diseases, including neurodegeneration and cancer. This is the second extension of the collaboration originally established in 2014

Global Pharma | 29/07/2021 | By Darshana

AstraZeneca completes acquisition of Alexion Pharmaceuticals

AstraZeneca completes acquisition of Alexion Pharmaceuticals

AstraZeneca completed the acquisition of Alexion Pharmaceuticals, (Alexion). The closing of the acquisition marks the company?s entry into medicines for rare diseases and the beginning of a new chapter for AstraZeneca

Global Pharma | 23/07/2021 | By Darshana

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology